Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Clinical trial NCT02468102 · COMPLETED

Trial details

NCT number: NCT02468102
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Coronary Syndrome Venous Thrombosis Pulmonary Embolism Atrial Fibrillation

Start date: 2015-06-15
Primary completion: 2018-12-31
Enrollment: 99999

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.